mots-c peptide uae | mitochondrial peptide research guide | bodypharm uae.

MOTS-C UAE researchers now have access to pharmaceutical grade MOTS-C 32mg through BodyPharm UAE. MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide (MDP) encoded within the 12S ribosomal RNA gene of the mitochondrial genome. First characterised in 2015 by Lee and colleagues at the University of Southern California, MOTS-C UAE research has expanded significantly since its initial discovery, positioning it as a key tool for studying mitochondrial signalling and metabolic regulation in laboratory models.

Unlike nuclear-encoded peptides, MOTS-C is expressed directly from mitochondrial DNA, a property that makes it a unique research tool for investigating the cross-talk between mitochondrial and nuclear gene expression pathways.

Research indicates that MOTS-C UAE laboratory studies centre on the peptide's activation of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. Studies suggest MOTS-C activates AMPK by modulating the methionine-folate cycle, leading to a reduction in purines and an increase in AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a known AMPK activator.

AMPK activation in turn regulates glucose uptake, fatty acid oxidation, and mitochondrial biogenesis across multiple cell types. Preliminary findings from cell culture and animal model studies suggest MOTS-C may influence insulin sensitivity pathways through this AMPK-dependent mechanism, an area of active investigation in the MOTS-C UAE research community.

Since its characterisation in 2015, the published literature on MOTS-C has expanded across several research domains. The foundational study by Lee et al., published in Cell Metabolism, characterised the peptide's role in regulating AMPK and glucose metabolism in cell and animal models. Subsequent studies have examined MOTS-C's effects in the context of:

• Insulin resistance models in skeletal muscle cell cultures
• Age-related metabolic changes in animal studies
• Exercise physiology and physical performance models in rodents
• Inflammation and immune regulation in preclinical settings

Research published in Nature Aging (2021) reported that MOTS-C levels change with age and that exogenous administration in aged mouse models influenced metabolic and physical performance parameters. These findings have generated interest in the peptide as a research tool for studying ageing-associated metabolic change, though findings remain at the preclinical stage.

Studies indicate MOTS-C may function as an exercise-inducible mitochondrial signal. Research has observed increases in circulating MOTS-C in human subjects following aerobic exercise, suggesting the peptide may be part of the cell-to-cell signalling cascade activated by physical activity. MOTS-C UAE research applications in exercise biology focus on understanding this signalling pathway in greater detail, particularly the interaction between mitochondrial peptides and skeletal muscle metabolism.

BodyPharm UAE supplies MOTS-C UAE as a lyophilised 32mg research peptide, independently verified for purity with HPLC and mass spectrometry. Each order includes a batch-specific Certificate of Analysis. Delivery covers Dubai, Abu Dhabi, Sharjah, and the wider UAE with same-day dispatch.

Quality criteria for MOTS-C UAE procurement should include purity documentation above 98%, mass spectrometry confirmation of molecular identity, and research-use-only supply terms.

Store MOTS-C UAE vials at 2-8 degrees Celsius, protected from light and moisture. Reconstitute using bacteriostatic water, adding liquid slowly and swirling gently. Use within standard peptide stability windows after reconstitution.

BodyPharm UAE supplies MOTS-C 32mg for research use with same-day delivery across Dubai. View the complete research peptide catalogue for all available compounds.

BodyPharm products are sold strictly for research purposes only and are not intended for human consumption, diagnosis, or treatment.